Symbol="LPCN"
AssetType="Common Stock"
Name="Lipocine Inc"
Description="Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceuticals for the treatment of metabolic and endocrine disorders. The company is headquartered in Salt Lake City, Utah."
CIK="1535955"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="22060700"
EBITDA="-13736378"
PERatio="None"
PEGRatio="0"
BookValue="5.45"
DividendPerShare="0"
DividendYield="0"
EPS="-2.36"
RevenuePerShareTTM="0.011"
ProfitMargin="0"
OperatingMarginTTM="-250.13"
ReturnOnAssetsTTM="-0.237"
ReturnOnEquityTTM="-0.352"
RevenueTTM="54990"
GrossProfitTTM="500000"
DilutedEPSTTM="-2.36"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-1"
AnalystTargetPrice="36.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="2.356"
PriceToBookRatio="0.953"
EVToRevenue="441.02"
EVToEBITDA="-1.116"
Beta="0.96"
num_52WeekHigh="10.41"
num_52WeekLow="3.3"
num_50DayMovingAverage="4.67"
num_200DayMovingAverage="6.08"
SharesOutstanding="5315800"
DividendDate="None"
ExDividendDate="None"
symbol="LPCN"
open="4.27"
high="4.27"
low="3.84"
price="4.15"
volume="74707.00"
latest_trading_day="2023-08-25"
previous_close="4.12"
change="0.03"
change_percent="0.7282%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="92"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="8"
Volume_recent_avg="187942"
Change_recent_avg="0.01"
Delta_recent_avg="0.27"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.31"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="8"
Aroon_momentum_negative="92"
image_negative_thumbnail_id_1="127"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0049.jpeg"
image_negative_thumbnail_id_2="1122"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0155.jpeg"
image_neutral_thumbnail_id_1="551"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0048.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="689"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_positive_thumbnail_id_2="994"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_professor_thumbnail_id_1="1178"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
image_professor_thumbnail_id_2="1184"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
